Perceived diabetes status is independently associated with glucose monitoring behaviour among type 2 diabetes mellitus patients☆
Abstract
Aims
To investigate if patients’ perceptions of their diabetes status is related to blood glucose self-monitoring (SMBG) behaviour, independent of self-reported disease severity.
Methods
The setting of this study was a cross-sectional study among 1561 patients, 18 years or older, who filled at least two prescriptions for any glucose lowering drug between March 2002 and 2003 in the Netherlands. Using a 30-item self-administered questionnaire, data on self-monitoring behaviour (frequency of test strip use and objective of self-monitoring), perceived diabetes status and disease severity were gathered. Type 1 diabetes mellitus patients were excluded. We used logistic regression to calculate odds ratios (OR) and their 95% confidence intervals (CI).
Results
About 54% of the patients (n
=
841) returned evaluable questionnaires. After exclusion of 97 type 1 diabetes mellitus patients, 744 type 2 diabetes mellitus patients were included. Practising SMBG was more common among patients who rated their diabetes status as poorly or moderately controlled compared to those who rated it (very) well-controlled (OR 1.93; 95% CI: 1.20–3.12). A better perceived diabetes status was more likely in those who performed SMBG infrequently compared to those who performed SMBG frequently (p-value for trend
=
0.001). Self-reported factors of disease severity and personalised objectives did not affect these associations considerably.
Conclusions
Among type 2 diabetes mellitus patients, SMBG behaviour is associated with patients’ perceptions of diabetes status, irrespective of the self-reported disease severity.
Keywords: Self-monitoring of blood glucose, Blood glucose test strips, Diabetes status, Patient characteristics, Cross-sectional survey
To access this article, please choose from the options below
☆ Previously presented at the 20th International Conference on Pharmacoepidemiology. Storimans M.J., Floor-Schreudering A., Klungel O.H., Talsma H., de Blaey C.J. Pharmacoepidemiol drug saf 2004. 13 Suppl. 1: S208–S209.
PII: S1751-9918(08)00005-3
doi:10.1016/j.pcd.2008.01.003
© 2008 Primary Care Diabetes Europe. Published by Elsevier Inc. All rights reserved.
